Galera Therapeutics Files Form 425
Ticker: GRTX · Form: 425 · Filed: Apr 14, 2026
Sentiment: neutral
Topics: filing, prospectus, business-combination
TL;DR
Galera Therapeutics filed a 425 form on 4/14/26. Prospectus/business combo related.
AI Summary
Galera Therapeutics, Inc. filed a Form 425 on April 14, 2026, related to prospectuses and business combinations. The filing includes a 425 document and a graphic image. Galera Therapeutics is a pharmaceutical preparations company incorporated in Delaware.
Why It Matters
This filing indicates potential corporate actions or communications related to securities, which could impact investors' understanding of the company's strategic direction.
Risk Assessment
Risk Level: low — Form 425 filings are typically informational and do not represent immediate financial transactions or significant operational changes.
Key Numbers
- 0001193125-26-155094 — SEC Accession Number (Unique identifier for the filing)
- 001-39114 — File Number (Associated SEC file number)
Key Players & Entities
- Galera Therapeutics, Inc. (company) — Subject of the filing
- 0001563577 (company) — CIK for Galera Therapeutics, Inc.
- 2026-04-14 (date) — Filing date
- 101 LINDENWOOD DRIVE SUITE 225 MALVERN PA 19355 (address) — Mailing and Business Address
FAQ
What is the primary purpose of a Form 425 filing?
A Form 425 filing is used for prospectuses and communications related to business combinations.
When was this specific Form 425 filed by Galera Therapeutics, Inc.?
This Form 425 was filed on April 14, 2026.
What is the CIK number for Galera Therapeutics, Inc.?
The CIK number for Galera Therapeutics, Inc. is 0001563577.
What is the business address of Galera Therapeutics, Inc. as listed in the filing?
The business address is 101 LINDENWOOD DRIVE SUITE 225 MALVERN PA 19355.
What SIC code is associated with Galera Therapeutics, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 425 (Form 425) was filed with the SEC on April 14, 2026 regarding Galera Therapeutics, Inc. (GRTX).